The Effects of Corneal Collagen Cross-linking
Launched by RUSH EYE ASSOCIATES · Oct 16, 2012
Trial Information
Current as of April 26, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 10-70, willing to participate, diagnosis of corneal ectasia disorder
- Exclusion Criteria:
- • Unwilling or unable to participate in trial
About Rush Eye Associates
Rush Eye Associates is a leading clinical trial sponsor dedicated to advancing ophthalmic research and improving patient outcomes through innovative studies and therapies. With a team of experienced ophthalmologists and research professionals, the organization focuses on a wide range of eye diseases and conditions, striving to enhance vision health and quality of life. By collaborating with academic institutions and healthcare providers, Rush Eye Associates is committed to conducting rigorous clinical trials that adhere to the highest ethical standards and regulatory guidelines, ensuring the safety and well-being of all participants. Their mission is to contribute to the evolving landscape of eye care through evidence-based practices and cutting-edge treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amarillo, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials